Ikarian Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-56,594
Closed -$18.5M 170
2025
Q2
$18.5M Buy
56,594
+25,000
+79% +$6.92M 6.11% 4
2025
Q1
$8.53M Buy
+31,594
New +$8.12M 2.78% 14
2024
Q4
Sell
-8,741
Closed -$2.4M 173
2024
Q3
$2.4M Buy
+8,741
New +$2.28M 0.75% 69
2024
Q2
Sell
-51,541
Closed -$8.14M 114
2024
Q1
$7.7M Buy
+51,541
New +$8.6M 2.1% 40
2023
Q4
Hold
0
143
2022
Q4
Sell
-2,800
Closed -$560K 88
2022
Q3
$560K Sell
2,800
-58,437
-95% -$11.1M 0.28% 79
2022
Q2
$8.93M Buy
61,237
+60,000
+4,850% +$8.51M 3.7% 19
2022
Q1
$201K Buy
1,237
+42
+4% +$6.4K 0.06% 166
2021
Q4
$204K Sell
1,195
-266
-18% -$49.4K 0.06% 155
2021
Q3
$276K Buy
+1,461
New +$274K 0.06% 198
2021
Q2
Hold
0
219
2021
Q1
Hold
0
299
2020
Q4
Hold
0
237
2020
Q3
Hold
0
178
2020
Q2
Hold
0
171
2020
Q1
Hold
0
158

Other funds holding ALNY